ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $70,355,000 | +21.5% | 408,807 | -11.4% | 0.02% | +28.6% |
| Q2 2021 | $57,903,000 | -29.9% | 461,416 | -24.3% | 0.01% | -36.4% |
| Q1 2021 | $82,611,000 | +19.7% | 609,179 | +12.9% | 0.02% | +10.0% |
| Q4 2020 | $69,003,000 | +81.6% | 539,338 | +59.7% | 0.02% | +53.8% |
| Q3 2020 | $37,997,000 | +68.5% | 337,665 | +42.7% | 0.01% | +62.5% |
| Q2 2020 | $22,546,000 | +90.2% | 236,657 | +79.4% | 0.01% | +60.0% |
| Q1 2020 | $11,853,000 | +3052.4% | 131,891 | +1760.8% | 0.01% | – |
| Q4 2019 | $376,000 | +25.8% | 7,088 | -6.2% | 0.00% | – |
| Q3 2019 | $299,000 | -7.4% | 7,556 | -3.8% | 0.00% | – |
| Q2 2019 | $323,000 | -14.6% | 7,852 | -3.3% | 0.00% | – |
| Q1 2019 | $378,000 | +35.5% | 8,116 | +26.7% | 0.00% | – |
| Q4 2018 | $279,000 | -13.6% | 6,405 | +13.6% | 0.00% | – |
| Q3 2018 | $323,000 | +17.0% | 5,640 | -0.7% | 0.00% | – |
| Q2 2018 | $276,000 | +26.0% | 5,682 | +1.3% | 0.00% | – |
| Q1 2018 | $219,000 | -86.9% | 5,611 | -87.9% | 0.00% | -100.0% |
| Q3 2016 | $1,673,000 | +98.2% | 46,216 | +44.6% | 0.00% | – |
| Q1 2016 | $844,000 | +16780.0% | 31,967 | +18704.1% | 0.00% | – |
| Q2 2015 | $5,000 | -99.9% | 170 | -99.9% | 0.00% | -100.0% |
| Q2 2014 | $9,614,000 | +15.4% | 283,027 | +17.2% | 0.00% | +33.3% |
| Q1 2014 | $8,332,000 | +110.4% | 241,500 | +141.5% | 0.00% | +50.0% |
| Q4 2013 | $3,960,000 | +78.1% | 100,000 | 0.0% | 0.00% | +100.0% |
| Q3 2013 | $2,223,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |